See All Slides - tctmd.com

Slides

Presentation THT 2026

Antagonist: Deep Phenotyping and Phenomapping Has Been and Will Continue to Be A Mirage in Understanding the Mechanisms and Tailoring Treatment for HFpEF.

Presenter: Milton Packer

March 02, 2026

Presentation THT 2026

Implantable Pressure-Base Remote Monitoring Devices: What are the Differences?

Presenter: Liviu Klein

March 02, 2026

Presentation THT 2026

Clinical Viewpoint: Fallout from the IABP Shock II and Alt-Shock Studies

Presenter: Joyce Wanglee Wald

March 02, 2026

Presentation THT 2026

Protagonist: HFpEF is Highly Heterogeneous, Requiring a Multimodal Precision Medicine Approach for True Progress.

Presenter: Sanjiv J. Shah

March 02, 2026

Presentation THT 2026

Perioperative Management and Outcomes of Heparin-Induced Thrombocytopenia in Patients Undergoing HeartMate 3 Left Ventricular Assist Device Implantation: A Case Series

Presenter: Vaidehi Mendpara

March 02, 2026

Presentation THT 2026

Remote Monitoring to Optimize GDMT Beyond Diuretics

Presenter: Lynne Warner Stevenson

March 02, 2026

Presentation THT 2026

Introduction: The Hemodynamic Basis of the Use of IABP in AMI- and HF-Shock

Presenter: Francesco Castagna

March 02, 2026

Presentation THT 2026

HeartCon: Pioneering VAD Development in China

Presenter: Xiaocheng Liu

March 02, 2026

Presentation THT 2026

Predicted vs. Observed 3-Year Mortality in the ALT FLOW Early Feasibility Study Cohort

Presenter: Javed Butler

March 02, 2026

Presentation THT 2026

Disentangling The Central, Peripheral And Hematological Mechanisms Of Benefit Of Sotatercept On Exercise Performance In Pulmonary Arterial Hypertension

Presenter: Yogesh Reddy

March 02, 2026

Advertisement

Slides

Antagonist: Deep Phenotyping and Phenomapping Has Been and Will Continue to Be A Mirage in Understanding the Mechanisms and Tailoring Treatment for HFpEF.

Implantable Pressure-Base Remote Monitoring Devices: What are the Differences?

Clinical Viewpoint: Fallout from the IABP Shock II and Alt-Shock Studies

Protagonist: HFpEF is Highly Heterogeneous, Requiring a Multimodal Precision Medicine Approach for True Progress.

Perioperative Management and Outcomes of Heparin-Induced Thrombocytopenia in Patients Undergoing HeartMate 3 Left Ventricular Assist Device Implantation: A Case Series

Remote Monitoring to Optimize GDMT Beyond Diuretics

Introduction: The Hemodynamic Basis of the Use of IABP in AMI- and HF-Shock

HeartCon: Pioneering VAD Development in China

Predicted vs. Observed 3-Year Mortality in the ALT FLOW Early Feasibility Study Cohort

Disentangling The Central, Peripheral And Hematological Mechanisms Of Benefit Of Sotatercept On Exercise Performance In Pulmonary Arterial Hypertension

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content